drugset / Trial / NCT06858865
A Study to Evaluate the Safety and Pharmacokinetics of AD-228A Compared to Coadministration of AD-2281 and AD-2282
RandomizedCrossoverOpen-labelTreatment
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-228A in healthy subjects.
Timeline
- Start
- 2025-07-12
- Primary completion
- 2025-08-14
- Completion
- 2025-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AD-2281 | Unknown | — | Oral |
| Subject | AD-2282 | Unknown | — | Oral |
| Subject | AD-228A | Unknown | — | Oral |